Introduction
Pre-operative differentiation between benign and malignant tumors is crucial in parotid gland surgery since the chosen surgical technique depends not only on the location of the tumor but also on the histologic type [1] [2] [3] [4] . When a tumor is malignant, the total parotidectomy is indicated but in these cases the facial nerve may be resected or damaged while in benign neoplasms, which mainly involves the superficial lobe, a 'limited' or preneural parotidectomy is considered appropriate. An inaccurate preoperative diagnosis renders the informed consent description and discussion difficult, as the documentation of patient's willingness to be placed at risk for post-surgical complications such as facial nerve is crucial. Furthermore misdiagnosis could result in both hazardous under-treatment, and potentially avoidable overtreatment with permanent facial static and dynamic disfigurement. Fine-needle aspiration cytology (FNAC) guided by ultrasound (US) imaging is widely used to evaluate both neoplastic and inflammatory lesions of the salivary glands, albeit with variable success; sensitivity ranges from 57% to 98%, specificity from 56% to 100%, and accuracy from 78% to 98% [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] which also depends on the expertise and experience of the pathologist. FNAC is obtained in all salivary gland nodules, and normally performed in reference centers dealing with parotid gland tumors. Some authors support the role of cytology only in selected groups while others state that pre-surgical FNAC does not impact on the surgical handling of these lesions [7, 17] , highlighting the importance of preoperative imaging in surgical planning [8, 18, 19] .
High resolution US and magnetic resonance (MR) examinations are the primary imaging techniques for the evaluation of lesions of the major salivary glands. As parotid lesions are localized in the superficial lobe in >90% of cases, it would seem that US, as a readily available, cost-effective and harmless technique, is the examination of choice. Moreover the application of parametric US techniques, including color-Doppler, US contrast agents and more recently, ultrasound elastography (USE) for assessing the lesion stiffness/elasticity characteristics, has been advocated to be useful for differentiating between different types of salivary gland lesions [20, 21] . MR imaging is usually the second level imaging modality requested and the MR imaging findings of salivary gland tumors have been previously described [22] [23] [24] [25] [26] [27] . General MRI features signifying malignancy are irregular margins, extra-glandular infiltration, perineural spread, and secondary lymphadenopathy [18] with low signal intensity and irregular lesion margins on T2-weighted MR images [22, 23] . However, the reported sensitivities and specificities of these findings are low with considerable overlap [20, 21, 26, 27] .
USE is a promising technique for diagnostic imaging and has potential for differentiating benign from malignant lesions in the parotid gland. USE has also been proven to be useful in differentiating between noninvasive benign and malignant lesions in other organs [28] [29] [30] [31] [32] .
The aim of this study was to examine whether the combination of conventional US imaging with USE improves the evaluation of parotid gland lesions and to determine which cut-off elasticity value would be the ideal for the differentiation between benign and malignant lesions. Furthermore, we pursued a secondary goal: to determine the elasticity of various benign tumors.
Materials and methods
Prospective analysis of salivary gland tumors by the means of B-mode US and real-time qualitative and quantitative USE was performed. The examined group consisted of 65 consecutive patients with parotid gland tumors, treated surgically in a single tertiary center, 29 female and 36 male subjects, aged 18-84 years (median = 56 years). All subjects gave written informed consent. The research was carried out in accordance to the ethical guidelines of the Declaration of Helsinki and approved by the Department Board.
Evaluation was performed by means of B-mode US, color-Doppler US (CDUS) and quasistatic USE using ACCUVIX A30, RS 80 A (Samsung Medison Co. Ltd., Seoul, Korea). USE was conducted by Elastoscan™ software (Samsung Medison, Korea) installed in the same US unit. All evaluation was operated by an experienced radiologist who was blinded to clinical, cytological or histological characteristics. The study was carried out with a high frequency (10-18 MHz) linear US transducer, placed gently on patient's neck in hyperextension, while lying in supine position, with axial and longitudinal scanning. For each lesion we considered the following criteria: echogenicity, margins, vascularization, and capsule definition. Signs of possible benignity were considered the homogeneous hypoechogenicity or isoechogenicity, regular well defined margins with an eventual capsule, and slight vascularization. Signs indicating of malignancy were dis-homogeneous internal echogenicity, irregular or spiculated margins with no capsule, haphazard irregular and/or intense intra-nodular vascularization. The radiologic volume of each tumor was assessed (using the formula: p/6 x height x length x width). For elastography with elasticity contrast index (ECI) evaluation, the patient was asked to perform a breath hold for 3-4 seconds to allow the acquisition. No external compression with the transducer was needed as Elastoscan™ uses the pulsations of the carotid artery (in vivo compression) for the elastography response. The operator performed the examination in longitudinal planes and then drew the region of interest (ROI) to include the nodule only. Within the ROI the software assessed the elasticity contrast index ECI, a semiquantitative stiffness evaluation.
On the elastograms (placed on the left side of the screen, side by side with the B-mode image) the nodules and the parotid were color coded depending on their stiffness with a colorimetric scale on the screen indicating the corresponding hard and soft areas, color coded red and blue respectively. The largest diameter of the suspicious lesion was included in the image. A ROI as described above was manually placed by the operator. Elastogram was considered optimal when the screen quality indicator turned to green (multiple boxes that change color from red, to yellow or green). Then the ECI value was computed and displayed on the screen. A high ECI value index indicated that the parotid nodule was hard and presumably malignant [32] .
All patients underwent FNAC, thereafter surgery, within one month of USE examination. Histopathology was available in all patients.
Statistical analysis
Statistical analysis was performed by means of Spearman's rank correlation coefficient for the age analysis, Kruskal-Wallis Test for more than two variables (concerning histology) and Mann-Whitney U Test for two variables (benign/malignant tumor's correlation). Cutoff values for continuous variables were calculated by receiver operation characteristic (ROC) analysis. Likelihood ratios were presented. The best cut-off point was defined by the highest sensitivity and specificity.
Results
We excluded 2 patients from this study because we could not perform a reliable elastographic examination due to excessive carotid artery pulsations. All the remaining patients were successfully evaluated and they underwent a superficial parotidectomy in cases of suspected benign tumor (n=49) and a total parotidectomy in case of presumed malignant tumors, with (n=5) or without neck dissection (n=9) depending on the histological subtype and tumor extension. Delayed neck dissection (n=7) was performed on 20 days average following surgery in case of misdiagnosed malignant tumor. Adjuvant radiotherapy and chemotherapy were administered according to the 'National Comprehensive Cancer Network' (NCCN) guidelines.
The smallest diameter of the parotid lesion was of 6 mm and the largest was of 57 mm. The median tumor volume was of 5.04 cm.
Histology results showed 47 patients with benign and 16 patients with malignant tumors: pleomorphic adenoma (n=18) (fig 1) , Warthin tumor (n=17) (fig 2) , mucoepidermoid carcinoma (n=5), oncocytoma (n=5), malignant lymphoma (n=3), lymphoepithelial cyst (n=3), ductal cyst (n=2), benign vascular tumor (n=2), squamous cell carcinoma (n=2), acinic cell carcinoma (n=2) (fig 3) , salivary duct carcinoma (n=2), and squamous cell carcinoma metastasis (n=2).
Using conventional parameters only, the observer suggested a malignant lesion in 20/63 (31.7%) cases and benign in 43/63 (68.3%) cases (accuracy: 61.8%).
ECI calculated for each lesion is shown in Table I .
The diagnostic performance of each individual US criteria, ECI, and ECI combined with each individual US criteria, was statistically calculated and presented in Table II . The best result was found when ECI performed alone (the most accurate parameter), since with a cut-off value of ECI>3.5 the accuracy was 90.5%, sensitivity of 93.7%, and specificity of 89.4%. When combined with other US criteria ECI showed a relatively minor diagnostic performance. FNAC was not diagnostic in 12/63 cases (19.0%) and in 8/63 (12.7%) cases the FNAC diagnosis did not correspond to the final histology: FNAC suggested a benign lesion when a malignant tumor was the surgical and histology result. FNAC sensitivity, specificity, predictive positive value, negative predictive value and accuracy calculated on 51 patients were 33.3%, 100%, 100%, 82.9%, and 86.2% respectively.
Discussions
USE is a sonographic technique that assesses the tissue stiffness. As malignant tissue is generally stiffer than benign tissue, therefore, interest has been recently focused on the ability of USE as an aid in the differential diagnosis between benign and malignant salivary gland lesions. The technique has already gained attention for the lesions of the head and neck region [33] [34] [35] with promising results, particularly for thyroid lesions [36] .
However, there is limited evidence for the usefulness of USE in the differential diagnosis of parotid tumors [21, [37] [38] [39] [40] . A typical sonoelastographic pattern for pleomorphic adenomas could not be demonstrated by Dumitriu et al [21] . Although it has been proposed that a semiquantitative 4-point elastographic score, adapted from a breast elastography score [39] can be used in parotid gland lesions, our experience suggests that such a scoring system is inadequate to classify and distinguish benign from malignant masses as both malignant and benign parotid tumors are in general markedly heterogeneous. For example, both mucoepidermoid and adenoid cystic carcinoma (which are the most frequent parotid malignant tumors) are, in the majority of cases, formed by a mixture of stiff and soft tissues. For this reason the maximum score of 4 is rarely encountered in the parotid malignancies. [37] assessed the parotid tumors by measuring the elasticity in a purely quantitative way (kPa, m/ sec at shear wave elastography) and found a significant difference between pleomorphic adenomas and Warthin tumors elasticity quantitative values. However, the authors observed little benefit in the benign-malignant differentiation of parotid tumors, particularly as pleomorphic adenoma quantitative values were similar and overlapping with malignant tumors. In particular, the observed intralesional variability of stiffness, which in pleomorphic adenoma can be high due to the tissue heterogeneity, led to the conclusion that elastography in parotid glands is unsuitable for excluding malignancy [37] .
Using the same technique of shear wave elastography in 43 parotid tumors, another group found good performance in parotid gland lesions [39] ; the mean elasticity values, in kPa, differed significantly between the lesions and the normal parenchyma and furthermore, differed significantly between the benign and malignant lesions. A meta-analysis published in 2015 [40] considered 9 eligible studies with no publication bias on USE for salivary gland masses benign-malignant differentiations, with a total of 581 lesions, and found good performance with a pooled sensitivity and specificity of 76% (95% confidence interval [CI] ) and 73% (95% CI) respectively. The results showed that the malignant lesions were commonly stiffer than the benign ones, but there was still a substantial overlap between the elastographic properties of malignant and benign parotid lesions. The authors suggested that USE can be used as an adjunct to conventional US for the evaluation of salivary glands, however its overall accuracy cannot confidently obviate, in the routine clinical practice, the need of biopsy. All these studies used the traditional form of elastography, the free-hand compression USE, which is an operator-dependent technique, with the drawback that the amount of the applied external pressure, affects the tissue elasticity detected. We used the quasistatic USE with the compression detected and measured from the carotid artery pulsations, possibly a more accurate technique.
In the present study, for the first time we evaluated USE with a quasistatic technique (Elastoscan™) in which a semiquantitative evaluation by means of ECI index is used to differentiate parotid tumors. In this technique a single superimposed ROI included the maximum lesional tissue possible and assessed the tissue stiffness at carotid pulsations. A statistically significant difference between benign and malignant tumor mean elasticity (p<0.001) was observed. The ECI cut-off value of 3.5 for the differential diagnosis between benign and malignant tumor considered alone was superior in terms of sensitivity, specificity, and accuracy to the other US parameters, except for echogenicity and capsule definition which were more sensitive but less specific. Whereas, when combined with the other US criteria, ECI showed an overall minor diagnostic performance. Diagnostic performance was the lowest with the B-mode features (accuracy 61.8%). FNAC was found to be less accurate in comparison with B-mode, color Doppler US, and USE with a high percentage of non-diagnostic results (19%) and low sensitivity (33.3%).
In our experience, on B-mode benign tumors are usually well-defined, often with a typical homogeneity, may contain calcification, and are well or sparsely vascularized. They may also show features suggesting specific abnormalities, such as sharp borders, lobulated contours, posterior acoustic enhancement in pleomorphic adenoma, cystic areas in Warthin tumors, calcifications representing phleboliths in hemangiomas, or oval and hypoechoic appearance with hyperechoic linear structures in lipomas. Regarding malignant lesions, characteristic features are hypoechoic inhomogeneous structure, irregular and poorly defined margins, local invasion into surrounding soft tissues, and pathologic lymph nodes.
A peculiar finding was the fact that pleomorphic adenoma, a benign tumor, showed a high ECI value: median of 3.12 (range 2.2-4.43) and thus proved to be difficult to differentiate from malignancy, with overlapping ECI values. In our series ECI values were high in pleomorphic adenomas, in 3 cases higher than the cutoff value; however in all these 3 cases, at least two US parameters suggested a benign disease. On the contrary, the other common benign tumor, the Warthin tumor, was soft, with a median of ECI of 1.87 (range 1.1-2.6) and we concluded that the ECI value may be a helpful finding in differentiating the pleomorphic adenoma from the Warthin tumor when the result of FNAC is inconclusive. In our 6 case series that were diagnosed preoperatively as Warthin tumor using FNAC, while the final pathological reports documented pleomorphic adenoma; in only 2/6 of cases pleomorphic adenoma diagnosis could be heavily suspected based only on US findings, whereas USE made the correct diagnosis of pleomorphic adenoma with a median ECI value of 2.9. Further studies should investigate the value of ECI in differentiating Warthin's tumor from pleomorphic adenoma especially in the cases in which baseline US or FNAC is not valuable enough to differentiate between the two tumors.
We have to mention as a limitation that the ECI values may slightly differ according to the strength of the pulsation from the carotid artery depending on age, atherosclerosis, and hypertension. Due to this issue, 2 patients were excluded from this study because we could not perform a reliable elastographic examination due to excessive carotid artery pulsations. Another bias was represented by the fact that only one expert and experienced USE operator performed the examination and the interobserver or intra-observer variability were not assessed. Furthrmore, it is known that cystic lesion in the thyroid yield false results in the USE evaluation [28, 29, 35, 41] . However in our cohort, cystic lesions in the parotid lesions were rare, and therefore we could not statistically evaluate this known confounding factor on ECI.
As a conclusion of these preliminary results we can mention that our study showed that USE with ECI index measurement improves the sensitivity of US for discriminating preoperatively benign from malignant parotid lesions. However, the user should be aware that pleomorphic adenomas are stiffer than other benign lesions. Therefore, we suggest the use of USE as an additional tool to conventional US evaluation in the diagnosis of salivary gland lesions. Larger and multi-center studies can better define the value of USE with ECI evaluation for parotid masses.
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